Convenient cash-pay weight loss, low introductory price, oral/needle-free alternatives, rapid clinician access and prescription delivery. Public pages mix injection and oral programs with hormone/sexual-health offers.
Read: adult cash-pay weight-loss consumers seeking convenience, needle-free options or transfer from another provider; enclomiphene and tadalafil target men's-health needs.
GLP injection promos: semaglutide $197 first/$297 regular; tirzepatide $349 first/$449 regular. Oral shop prices conflict with landing pages; 3-month plans and dose surcharges labeled.
- https://biopreventative.com/ ↗
- https://biopreventative.com/shop/ ↗
- https://biopreventative.com/glp-1/ ↗
- https://biopreventative.com/tirzepatide-weight-loss/ ↗
- https://biopreventative.com/semaglutide-oral-dissolving-tablets/ ↗
- https://biopreventative.com/tirzepatide-oral-dissolving-tablets/ ↗
- https://biopreventative.com/product/tirzepatide-oral-plan-3/ ↗
- https://biopreventative.com/enclomiphene-treatment/ ↗
- https://biopreventative.com/sermorelin-injectable/ ↗
- https://biopreventative.com/semaglutideoraldrops/ ↗
- https://biopreventative.com/malemd-alpha-3-1/ ↗
- https://biopreventative.com/landing-page/ ↗
- https://biopreventative.com/semaglutide-active-ingredient-in-ozempic-prescribed-online/ ↗
- https://biopreventative.com/checkout/?c1=testosterone ↗
- https://biopreventative.com/checkout/?c1=semaglutide3 ↗
- https://biopreventative.com/checkout/?c1=sermorelin3 ↗
- https://biopreventative.com/refund-policy/ ↗
- https://biopreventative.com/terms-and-conditions/ ↗
Terms ambiguously name MDI (MD Integrations) OR TelegraMD LLC as associated partner agencies and say they are not medical providers. Current employing state practice/assignment not resolved. Site presents clinicians including Divya Venkat, Anchal Khosla, Yeisel Castanedo, Calle Thompson, James Ross and Jonathan Silverman; roster does not establish actual patient prescriber.
Unnamed US compounding-pharmacy partners; tadalafil page refers to a New Jersey partner without legal name. Terms say platform is not a pharmacy. Current named compounder and molecule/state assignment not established; LegitScript/FDA quality language is a company claim.
Google / Meta / LinkedIn public-library snapshots reviewed 16 Oct 2026. See channel observations and direct lookup links.
- https://adstransparency.google.com/?region=US&domain=biopreventative.com ↗
- https://www.facebook.com/ads/library/?active_status=active&ad_type=all&country=US&is_targeted_country=false&media_type=all&q=%22BioPreventative%22&search_type=keyword_exact_phrase ↗
- https://www.linkedin.com/ad-library/search?accountOwner=BioPreventative&original_referer= ↗
BBB lists 11 July 2023 business start/incorporation. On-site testimonials describe 2022 use; those are not reliable founding evidence. Launch date remains unverified.
Founder not established. BBB lists Rayant Grant and Jeff Aririguzo as managing members, not explicitly founders.
Public site and FDA 2025 letter use 14508 Lincoln Blvd, Suite 121 #120, Miami FL 33176. Corporate forms differ: FDA/terms LLC versus refund policy Company Inc.; current registry identity not independently reconciled.
- https://biopreventative.com/ ↗
- https://www.bbb.org/us/fl/miami/profile/telemedicine/biopreventative-llc-0633-92038275 ↗
- https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/biopreventative-company-llc-dba-biopreventative-715505-09092025 ↗
- https://biopreventative.com/refund-policy/ ↗
First-party pages and public search-index results reviewed. This is not a measured Google position, traffic estimate or search-volume study. Pricing metadata can disagree with rendered product pages.